LLY vs JNJ
By Alex · Tickerpine
Eli Lilly and Company vs Johnson & Johnson, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | JNJ |
|---|---|---|
| Price | $1,273.46 | $263.81 |
| Market cap | $1.14T | $635.07B |
| P/E ratio | 42.7 | 40.0 |
| ROE | 102.29% | 20.02% |
| Profit margin | 33.53% | 16.20% |
| Revenue growth | 47.70% | 5.90% |
| Dividend yield | 0.54% | 2.03% |
| Beta | 0.45 | 0.21 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs JNJ in plain English
- LLY is the bigger company — about 1.8× the market cap of JNJ.
- JNJ is cheaper on earnings (P/E 40.0 vs 42.7).
- LLY earns a higher return on equity (102% vs 20%).
- LLY is growing revenue faster (48% vs 6%).
- JNJ has the higher dividend yield (2.03% vs 0.54%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.